- Home
- ORIS vs QNRX Comparison
ORIS vs QNRX Comparison
Compare ORIS & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIS
- QNRX
- Stock Information
- Founded
- ORIS 2014
- QNRX 2018
- Country
- ORIS China
- QNRX United States
- Employees
- ORIS N/A
- QNRX N/A
- Industry
- ORIS Farming/Seeds/Milling
- QNRX Medical/Dental Instruments
- Sector
- ORIS Consumer Staples
- QNRX Health Care
- Exchange
- ORIS Nasdaq
- QNRX Nasdaq
- Market Cap
- ORIS 5.3M
- QNRX 4.8M
- IPO Year
- ORIS 2024
- QNRX N/A
- Fundamental
- Price
- ORIS $0.14
- QNRX $12.98
- Analyst Decision
- ORIS
- QNRX
- Analyst Count
- ORIS 0
- QNRX 0
- Target Price
- ORIS N/A
- QNRX N/A
- AVG Volume (30 Days)
- ORIS 5.1M
- QNRX 835.8K
- Earning Date
- ORIS 01-01-0001
- QNRX 11-07-2025
- Dividend Yield
- ORIS N/A
- QNRX N/A
- EPS Growth
- ORIS N/A
- QNRX N/A
- EPS
- ORIS 0.17
- QNRX N/A
- Revenue
- ORIS $15,014,000.00
- QNRX N/A
- Revenue This Year
- ORIS N/A
- QNRX N/A
- Revenue Next Year
- ORIS N/A
- QNRX N/A
- P/E Ratio
- ORIS $0.85
- QNRX N/A
- Revenue Growth
- ORIS N/A
- QNRX N/A
- 52 Week Low
- ORIS $0.08
- QNRX $5.01
- 52 Week High
- ORIS $56.01
- QNRX $48.30
- Technical
- Relative Strength Index (RSI)
- ORIS 42.26
- QNRX 54.05
- Support Level
- ORIS $0.14
- QNRX $12.55
- Resistance Level
- ORIS $0.15
- QNRX $17.84
- Average True Range (ATR)
- ORIS 0.01
- QNRX 4.54
- MACD
- ORIS -0.00
- QNRX -0.20
- Stochastic Oscillator
- ORIS 4.91
- QNRX 15.11
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.